We are live on ! Find out more
KALV

KalVista Pharmaceuticals

Delisted

KALV was delisted on the 10th of June, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
TCM
1
TCG Crossover Management
California
$30.6M
FLSM
2
Frazier Life Sciences Management
California
$29.1M
VA
3
VR Adviser
New York
$26.3M
TCM
4
Tang Capital Management
California
$23.9M
SCM
5
Suvretta Capital Management
New York
$18.3M +$473K +51,327 +3%
BC
6
Boxer Capital
California
$14.8M
BlackRock
7
BlackRock
New York
$14.4M +$384K +41,604 +3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$14.2M -$17K -1,845 -0.1%
SVCM
9
Saturn V Capital Management
Texas
$12.7M +$2.68M +290,354 +26%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$9.94M +$369K +40,000 +4%
DCM
11
Driehaus Capital Management
Illinois
$9.32M +$192K +20,816 +2%
JFG
12
Jefferies Financial Group
New York
$9.27M -$1.57M -170,000 -14%
VC
13
Vivo Capital
California
$7.7M
Citadel Advisors
14
Citadel Advisors
Florida
$7.62M +$6.62M +718,211 +559%
MB
15
MPM BioImpact
Massachusetts
$6.85M +$7.02M +761,538 New
SCM
16
Silverarc Capital Management
Massachusetts
$6.48M -$28K -3,036 -0.4%
OM
17
Opaleye Management
Massachusetts
$6.48M -$1.87M -203,200 -22%
DCM
18
DAFNA Capital Management
California
$5.5M -$46.1K -5,000 -0.8%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$4.32M +$119K +12,941 +3%
State Street
20
State Street
Massachusetts
$4.02M +$248K +26,914 +6%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$3.78M +$1.7M +184,269 +78%
First Manhattan
22
First Manhattan
New York
$3.53M +$1.13M +122,900 +46%
CC
23
Commodore Capital
New York
$2.81M
Citigroup
24
Citigroup
New York
$2.7M +$211K +22,902 +8%
Goldman Sachs
25
Goldman Sachs
New York
$2.64M +$164K +17,827 +6%